Synthesis, Structures and Helicobacter Pylori Urease Inhibition of Schiff Base Vanadium Complexes Containing Acetohydroxamate Ligands

Ren Jin-Qi,Rao Qing-Zhu,Wang Yi-Nuo,Xu Fang-Yuan,Cheng Xiao-Shao,You Zhong-Lu
DOI: https://doi.org/10.11862/cjic.2014.106
2014-01-01
Abstract:Two new Schiff base vanadium complexes containing acetohydroxamate ligands, [(VL1)-L-II(HAHA)] (1) and [(VOL2)-O-V(AHA)] (2), where L-1 is the dianionic form of N,N'-bis(5-methylsalicylidene)ethane-1, 2-diamine, L-2 is the monoanionic form of 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-6-methylphenol, HAHA and AHA are the mono-anionic and di-anionic forms of acetohydroxamic acid, have been synthesized and characterized by physico-chemical methods and single-crystal X-ray diffraction. The V atoms in the complexes adopt octahedral coordination. Thermal stability and urease inhibitory activities of the complexes were studied. The percent inhibition of complexes 1 and 2 at the concentration of 100 mu mol.L-1 on Helicobacter pylori urease are 37.2% and 81.5%, respectively. Complex 2 has IC50 value of 21.5 mu mol.L-1. Molecular docking study indicates that there form effective interactions between complex 2 and the active site of the urease. CCDC: 961635, 1; 961636, 2.
What problem does this paper attempt to address?